Merit Medical Systems (MMSI) Receiving Somewhat Positive Press Coverage, Report Finds

News coverage about Merit Medical Systems (NASDAQ:MMSI) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned media coverage about the medical instruments supplier an impact score of 44.338145909413 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Merit Medical Systems (MMSI) traded down $0.65 during trading hours on Thursday, hitting $44.10. The company’s stock had a trading volume of 123,600 shares, compared to its average volume of 292,200. Merit Medical Systems has a 1 year low of $24.23 and a 1 year high of $46.40. The stock has a market cap of $2,210.00, a PE ratio of 73.50, a P/E/G ratio of 2.61 and a beta of 1.23. The company has a current ratio of 2.78, a quick ratio of 1.43 and a debt-to-equity ratio of 0.39.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.02. The firm had revenue of $179.30 million for the quarter, compared to analysts’ expectations of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The company’s revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.26 EPS. equities analysts expect that Merit Medical Systems will post 1.27 earnings per share for the current fiscal year.

A number of brokerages have recently weighed in on MMSI. ValuEngine lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Canaccord Genuity reissued a “buy” rating and issued a $45.00 price target on shares of Merit Medical Systems in a research report on Sunday, October 8th. Zacks Investment Research lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. BidaskClub downgraded Merit Medical Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, December 5th. Finally, Wells Fargo & Co restated an “outperform” rating and issued a $51.00 price objective (up previously from $46.00) on shares of Merit Medical Systems in a research note on Thursday, November 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. Merit Medical Systems currently has an average rating of “Buy” and an average target price of $43.77.

In related news, Director Kent W. Stanger sold 9,082 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $44.90, for a total transaction of $407,781.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Franklin J. Miller sold 10,000 shares of the firm’s stock in a transaction that occurred on Saturday, December 29th. The stock was sold at an average price of $43.93, for a total value of $439,300.00. Following the transaction, the director now owns 21,244 shares in the company, valued at $933,248.92. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,000 shares of company stock worth $1,416,379. 5.00% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/11/merit-medical-systems-mmsi-receiving-somewhat-favorable-press-coverage-analysis-finds.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply